General Information of DTT (ID: TTXU3EQ)

DTT Name Herpesvirus ubiquitin-specific protease (HAUSP) DTT Info
Gene Name USP7

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Preclinical Drug(s)
Patented Agent(s)
2 Patented Agent(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID26077642-Compound-Vif1 DMS9KCF N. A. N. A. Patented [1]
PMID26077642-Compound-Vif2 DMYXIS7 N. A. N. A. Patented [1]
------------------------------------------------------------------------------------
5 Preclinical Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ADC-01 DM19R28 Solid tumour/cancer 2A00-2F9Z Preclinical [2]
ADC-03 DM21I35 Solid tumour/cancer 2A00-2F9Z Preclinical [2]
HBX19818 DM6GSI1 Solid tumour/cancer 2A00-2F9Z Preclinical [3]
P22077 DMD8JIC Inflammation 1A00-CA43.1 Preclinical [4]
P5091 DMGIR3F Solid tumour/cancer 2A00-2F9Z Preclinical [5]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Deubiquitinases (DUBs) and DUB inhibitors: a patent review.Expert Opin Ther Pat. 2015;25(10):1191-1208.
2 Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics. Cancers (Basel). 2020 Jun 15;12(6):1579.
3 Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells. Mol Cancer Ther. 2009 Aug;8(8):2286-95.
4 P22077 inhibits LPS-induced inflammatory response by promoting K48-linked ubiquitination and degradation of TRAF6. Aging (Albany NY). 2020 Jun 9;12(11):10969-10982.
5 USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth. Biochem Pharmacol. 2017 May 1;131:29-39.